Sujets)
Humains , Mâle , Femelle , Sujet âgé , Sujet âgé de 80 ans ou plus , Clarithromycine/effets indésirables , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique , Inhibiteurs du cytochrome P-450 CYP3A/effets indésirables , Pyrimidines/métabolisme , Pyrimidines/usage thérapeutique , Pyrimidines/pharmacocinétique , Rhabdomyolyse/induit chimiquement , Sulfonamides/métabolisme , Sulfonamides/usage thérapeutique , Sulfonamides/pharmacocinétique , Acides gras monoinsaturés/métabolisme , Acides gras monoinsaturés/usage thérapeutique , Acides gras monoinsaturés/pharmacocinétique , Pravastatine/métabolisme , Pravastatine/usage thérapeutique , Pravastatine/pharmacocinétique , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/métabolisme , Transporteurs d'anions organiques , Transporteurs d'anions organiques sodium-indépendants/antagonistes et inhibiteurs , Polypeptide C de transport d'anions organiques , Interactions médicamenteuses , Atteinte rénale aigüe/induit chimiquement , Rosuvastatine de calcium , Fluorobenzènes/métabolisme , Fluorobenzènes/usage thérapeutique , Fluorobenzènes/pharmacocinétique , Membre 1B3 de la famille des transporteurs d'anions organiques appartenant aux transporteurs de solutés , Fluvastatine , Hyperkaliémie/induit chimiquement , Indoles/métabolisme , Indoles/usage thérapeutique , Indoles/pharmacocinétiqueRésumé
PURPOSE: To evaluate the effects of preconditioning with oils mixes containing ω3/ω6/ω9 associated with micro-currents on skin repair in rats. METHODS: One-hundred and eight Wistar rats randomized into G-1, G-2 and G-3 groups were treated with saline (0.9%), mix 1 (corn+soybean oils) and mix 2 (olive+canola+flaxseed oils), respectively, in a single dose (0.01ml/g) by gavage. Next, each group was subdivided into sham and stimulated subgroups. Pulsed-wave microcurrents (0.5 µA, 0.5 Hz) were applied to stimulated subgroups for 20 min. One hour later anesthetized rats were subjected to surgery. A dorsal incision (6 cm long) was carried out and closed with interrupted nylon sutures. Samples (1cm2) were harvested from the mid-portion of the incision on the 7, 14, 21 post-operative (P.O.) days. Variables were analyzed using Mann-Whitney/Dunn tests Significance level was set to 5 % (p<0.05). RESULTS: Micro-currents promoted increase of exudate and reduction of epithelialization on day 7 in G1 rats. Mixes 1/2 reduced vascularization on 7/14th days P.O. Both 1/2 mixes reduced fibrosis on day 14. Preconditioning with mix 1 led to increased expression of NF-kB on the 7th day. CONCLUSION: Preconditioning with microcurrents has pro-inflammatory effects while oil mixes 1 and 2 decrease fibrosis and vascularization in the proliferative phase of cicatrization. .
Sujets)
Animaux , Mâle , Électrothérapie/méthodes , Acides gras monoinsaturés/usage thérapeutique , Acides gras insaturés/usage thérapeutique , Peau/effets des médicaments et des substances chimiques , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Fibrose/anatomopathologie , Immunohistochimie , Répartition aléatoire , Rat Wistar , Reproductibilité des résultats , Peau/vascularisation , Peau/anatomopathologie , Facteurs temps , Résultat thérapeutiqueRésumé
OBJECTIVE: Postsurgical abdominal adhesions are common, serious postoperative complications. The present study compared the usefulness of 4% icodextrin and canola oil in preventing postoperative peritoneal adhesions. METHODS: Twenty-four Wistar albino rats were divided into three groups. Following a laparotomy, a serosal abrasion was made by brushing the cecum, and 3 mL of 0.9% NaCl, 4% icodextrin, or 3 mL of canola oil were intraperitoneally administered for the control, icodextrin, and canola oil groups, respectively. The abdomen was then closed. All of the rats were sacrificed at day 10. Macroscopic, histopathological, and biochemical evaluations were performed. The results were statistically analyzed using Kruskal-Wallis and ANOVA tests. RESULTS: Macroscopic analyses revealed that both canola oil and 4% icodextrin reduced adhesion formation, but the difference was not statistically significant (p = 0.17). The histopathological examinations revealed no significant differences in terms of giant cell, lymphocyte/plasmocyte, neutrophil, ICAM1, or PECAM1 scores. However, both canola oil and 4% icodextrin significantly reduced fibrosis (p = 0.025). In the canola oil group, the histiocytic reactions were significantly increased (p = 0.001), and the hydroxyproline levels were significantly lower than those in the other groups (p = 0.034). CONCLUSIONS: In the present study, canola oil was determined to be superior to 4% icodextrin in lowering hydroxyproline levels and increasing histiocytic reactions. Considering these results, we believe that canola oil is a promising agent for preventing adhesion formation.
Sujets)
Animaux , Femelle , Rats , Acides gras monoinsaturés/usage thérapeutique , Glucanes/usage thérapeutique , Glucose/usage thérapeutique , Maladies du péritoine/prévention et contrôle , Péritoine/chirurgie , Rat Wistar , Reproductibilité des résultats , Résultat thérapeutique , Adhérences tissulaires/prévention et contrôleRésumé
Background. The role of cholesterol in neoplasic cell growth and its inhibition by drugs has recently been studied. Cholesterol biosynthesis inhibitors have been used as adjuvants in the treatment of cancer and possibly as prophylactic in carcinogenesis. objetive. The objetive of the study was to determine the maximal tolerated doses (MTD) and toxic effects of fluvastatin in pediatric cancer patients. Methods. This study was carried out in a thirid level Social Security Hospital in Mexico City. We included pediatric patients from april 1996 to May 1997. All were terminal cancer patients who did not respond to conventional therapies. Fluvastatin was give p.o. at doses of 2 mg/kg/day dor 14 days every 4 weeks in three patients. Subsequent cohorts of three patients each had increments of 2 mg/kg/day of the drug until maximal tolerated doses were found. Toxic effects of the drug were evaluated by physical exploration, laboratory assays and a questionnaire given to each patient. Results. Twelve patients were included. Diagnoses included two osteosarcomas, eight central nervous system tumors, one lung tumor, and one Ewing's sarcoma. Ten patients died within 1 to 18 months. Two are aolive 22 months after inclusion into the study, both with anaplasic astrocytoma. A total of 27 courses wer administered. The MTD was 8 mg/kg/day. Toxic effects were insomnia, nausea, vomiting, abdominal distention and myalgias. Txocicity was dose-dependent. Laboratory assays demonstrated no significant changes during treatment. Conclusions. Fluvastatin can be safely used at doses of 8 mg/kg/day in pediatric patients with cancer. This dose should be used in additional trials